Microtubule-Targeting Agents: Advances in Tubulin Binding and Small Molecule Therapy for Gliomas and Neurodegenerative Diseases
International Journal of Molecular Sciences · 07.08.2025 · 26 (15) · 7652
DOI: 10.3390/ijms26157652 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.08.2025. Verfasst von Maya Ezzo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Université de Paris, Equipe Labellisée Ligue Contre le Cancer 2023, F-75015…. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Microtubules, Glioma, Tubulin. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National du Cancer, La Ligue contre le cancer Progamme Enfants Adolescent Cancer 2024, INCA PLBIO.
Abstract (Originalsprache)
Microtubules play a key role in cell division and cell migration. Thus, microtubule-targeting agents (MTAs) are pivotal in cancer therapy due to their ability to disrupt cell division microtubule dynamics. Traditionally divided into stabilizers and destabilizers, MTAs are increasingly being repurposed for central nervous system (CNS) applications, including brain malignancies such as gliomas and neurodegenerative diseases like Alzheimer’s and Parkinson’s. Microtubule-stabilizing agents, such as taxanes and epothilones, promote microtubule assembly and have shown efficacy in both tumour suppression and neuronal repair, though their CNS use is hindered by blood–brain barrier (BBB) permeability and neurotoxicity. Destabilizing agents, including colchicine-site and vinca domain binders, offer potent anticancer effects but pose greater risks for neuronal toxicity. This review highlights the mapping of nine distinct tubulin binding pockets—including classical (taxane, vinca, colchicine) and emerging (tumabulin, pironetin) sites—that offer new pharmacological entry points. We summarize the recent advances in structural biology and drug design, enabling MTAs to move beyond anti-mitotic roles, unlocking applications in both cancer and neurodegeneration for next-generation MTAs with enhanced specificity and BBB penetration. We further discuss the therapeutic potential of combination strategies, including MTAs with radiation, histone deacetylase (HDAC) inhibitors, or antibody–drug conjugates, that show synergistic effects in glioblastoma models. Furthermore, innovative delivery systems like nanoparticles and liposomes are enhancing CNS drug delivery. Overall, MTAs continue to evolve as multifunctional tools with expanding applications across oncology and neurology, with future therapies focusing on optimizing efficacy, reducing toxicity, and overcoming therapeutic resistance in brain-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Université de Paris, Equipe Labellisée Ligue Contre le Cancer 2023, F-75015 Paris, France.
ORCID-Profile: Maya Ezzo, Sandrine Etienne-Manneville
Förderung
- Institut National du Cancer
- La Ligue contre le cancer Progamme Enfants Adolescent Cancer 2024
- INCA PLBIO
Zitieren
APA
Ezzo, M., & Etienne-Manneville, S. (2025). Microtubule-Targeting Agents: Advances in Tubulin Binding and Small Molecule Therapy for Gliomas and Neurodegenerative Diseases. International Journal of Molecular Sciences, 26(15), 7652. https://doi.org/10.3390/ijms26157652
Vancouver
Ezzo M, Etienne-Manneville S. Microtubule-Targeting Agents: Advances in Tubulin Binding and Small Molecule Therapy for Gliomas and Neurodegenerative Diseases. International Journal of Molecular Sciences. 2025;26(15):7652. doi:10.3390/ijms26157652
BibTeX
@article{Ezzo2025,
author = {Ezzo, Maya and Etienne-Manneville, Sandrine},
title = {Microtubule-Targeting Agents: Advances in Tubulin Binding and Small Molecule Therapy for Gliomas and Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {15},
pages = {7652},
doi = {10.3390/ijms26157652}
}
EUVIMED